Evidence map›Paper›PMID 17107669›Full record

ArticleCardiovascular research2007

PUMA is critical for neonatal cardiomyocyte apoptosis induced by endoplasmic reticulum stress.

Philip Nickson, Ambrus Toth, Peter Erhardt

Open access · bronzeAbstract read
In one paragraph

Article in Cardiovascular research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 130 citations in OpenAlex.

  1. Lipotoxicity, ER Stress, and Cardiovascular Disease: Current Understanding and Future Directions.Cardiovascular & hematological agents in medicinal chemistry · 2024
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. The unfolded protein response in ischemic heart disease.Journal of molecular and cellular cardiology · 2018
    Review
  13. Increased free ZnJournal of cellular and molecular medicine · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Philip NicksonBoston Biomedical Research Institute, 64 Grove Street, Watertown, MA 02472, USA.
Ambrus Toth
Peter Erhardt
Boston Biomedical Research Institute · US

Funding

PREVENTION OF MYOCARDIAL ISCHEMIC INJURY BY RAF/ERKR01HL068126 · NHLBI · BOSTON BIOMEDICAL RESEARCH INSTITUTE · PI ERHARDT, PETER · 2003 to 2006
$1.5M
NHLBI NIH HHS R01 HL068126
6 · The paper itself

Abstract

objectivePuma (p53-upregulated modulator of apoptosis), a proapoptotic BH3-only member of the Bcl-2 protein family, has been implicated in the pathomechanism of several diseases, including cancer, AIDS, and ischemic brain disease. We have recently shown that Puma is required for cardiac cell death upon ischemia/reperfusion of mouse hearts. Since ischemia/reperfusion is also associated with endoplasmic reticulum (ER) stress, in the present study we investigated whether Puma contributes to the ER stress-dependent component of cardiomyocyte apoptosis.

methodsPrimary cultures of rat and mouse neonatal cardiomyocytes were treated with 3 muM thapsigargin or 100 ng mL(-1) tunicamycin. Puma levels were suppressed by adenoviral delivery of shRNA or targeted deletion of the puma gene. Puma expression was detected by RT-PCR and Western blotting. Apoptosis was assessed by TUNEL assay, caspase-3 cleavage, and cytochrome c release.

resultsWe have shown that in rat neonatal cardiac myocytes, thapsigargin or tunicamycin treatment led to ER-stress, transcriptional upregulation of Puma, and apoptosis. Most importantly, cardiac myocytes acquired resistance to ER stress-induced apoptosis if Puma expression was downregulated by adenoviral delivery of shRNA or eliminated by targeted deletion in knockout mice.

conclusionTaken together, our data indicate that Puma is a critical component of ER stress-induced apoptosis in cardiac myocytes, and inhibition of Puma activity may be used to treat cardiac infarcts or prevent heart failure by blocking ER stress-induced apoptosis.

Indexed as

AnimalsAnimals, NewbornApoptosisApoptosis Regulatory ProteinsBiomarkersBlotting, WesternCalcium-Transporting ATPasesCaspase 3Cell LineCells, CulturedCytochromes cEndoplasmic ReticulumGene DeletionGene ExpressionImmunohistochemistryIn Situ Nick-End LabelingApoptosis Regulatory ProteinsBiomarkersCalcium-Transporting ATPasesCaspase 3Cytochromes cProto-Oncogene Proteins c-bcl-2PUMA protein, mouseThapsigarginTumor Suppressor Protein p53Tumor Suppressor ProteinsTunicamycin

Identifiers

PMID17107669
PMCPMC1832123
OpenAlexW2119951348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.